Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fibrotech Therapeutics Pty. Ltd.

Division of Takeda Pharmaceutical Co. Ltd.
www.fibrotech.com.au

Latest From Fibrotech Therapeutics Pty. Ltd.

Major New VC Fund To Support Australian Biotech

A leading Australian venture capital firm has raised the largest ever amount for a private investment fund in the life sciences sector in the country, which will support both early- and mid-stage biotech and device research.

BioPharmaceutical Medical Device

Deal Watch: Likely Break-up Of AbbVie/Shire Merger Shuffles Planning At Both Companies

J&J Innovation Center facilitates a lung cancer immunotherapy collaboration between Aduro and Janssen. Pentamer turns to crowdfunding to finance its work on an Ebola vaccine, and a host of other transactions from a frantic deal-making week.

BioPharmaceutical Deals

Deals Shaping The Medical Industry, June 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced April through May 2014.

BioPharmaceutical Consumer
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Metabolic Disorders
  • Renal System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Takeda Pharmaceutical Co. Ltd.
  • Senior Management
  • Darren Kelly, CEO
  • Contact Info
  • Fibrotech Therapeutics Pty. Ltd.
    Phone: 3 9288 2546
    278 Collins St., Level 9
    Melbourne, 3000
    Australia
Advertisement
Advertisement
UsernamePublicRestriction

Register